Enhabit Inc

Enhabit Inc Stock Forecast & Price Prediction

Live Enhabit Inc Stock (EHAB) Price
$7.60

0

Ratings

  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$7.60

P/E Ratio

-4.72

Volume Traded Today

$434,280

Dividend

Dividends not available for EHAB

52 Week High/low

11.74/6.85

Enhabit Inc Market Cap

$383.7M

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $EHAB ๐Ÿ›‘

Before you buy EHAB you'll want to see this list of ten stocks that have huge potential. Want to see if EHAB made the cut? Enter your email below

EHAB Summary

The Enhabit Inc (EHAB) share price is expected to increase by 19.08% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered EHAB. Price targets range from $8 at the low end to $11 at the high end. The current analyst consensus for EHAB is a sell. Please note analyst price targets are not guaranteed and could be missed completely.

EHAB Analyst Ratings

About 0 Wall Street analysts have assigned EHAB 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Enhabit Inc to perform worse than the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on EHAB. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

EHAB stock forecast by analyst

These are the latest 20 analyst ratings of EHAB.

Analyst/Firm

Rating

Price Target

Change

Date

Joanna Gajuk
B of A Securities

Underperform

$8

Maintains

Jun 27, 2024
Whit Mayo
Leerink Partners

Market Perform

$8.5

Upgrade

May 14, 2024
Brian Tanquilut
Jefferies

Hold

$8.75

Downgrade

May 9, 2024
Ryan Langston
TD Cowen

Market Perform

$11

Maintains

Mar 11, 2024
A.J. Rice
UBS

Neutral

$9.5

Upgrade

Mar 7, 2024
Michael Wiederhorn
Oppenheimer

Perform


Maintains

Mar 7, 2024
Brian Tanquilut
Jefferies

Buy

$14

Maintains

Mar 6, 2024
Ryan Langston
TD Cowen

Market Perform

$12

Initiates

Dec 12, 2023
Jonathan Yong
Credit Suisse

Neutral

$12

Maintains

Aug 11, 2023
Jamie Perse
Goldman Sachs

Neutral

$13

Maintains

Jul 17, 2023
Jamie Perse
Goldman Sachs

Neutral

$15

Initiates

Mar 16, 2023
Jason Cassorla
Citigroup

Neutral

$18

Maintains

Feb 17, 2023
Jonathan Yong
Credit Suisse

Neutral

$15

Reiterates

Feb 16, 2023
Larry Solow
CJS Securities

Market Perform

$18

Initiates

Dec 13, 2022
Andrew Mok
UBS

Sell

$12

Initiates

Dec 8, 2022
Tao Qiu
Stifel

Buy

$17

Initiates

Dec 6, 2022
Jonathan Yong
Credit Suisse

Neutral

$15

Maintains

Nov 4, 2022
Michael Wiederhorn
Oppenheimer

Perform


Initiates

Oct 14, 2022
Brian Tanquilut
Jefferies

Buy

$20

Initiates

Aug 30, 2022
A.J. Rice
Credit Suisse

Neutral

$19

Initiates

Aug 25, 2022

EHAB Company Information

What They Do: Provides home health and hospice services.

Business Model: Enhabit, Inc. generates revenue through its diverse range of home health and hospice services. The company offers skilled nursing, therapy, and personal care services, as well as specialized hospice care for terminally ill patients, which allows it to cater to a broad demographic with varying health needs.

Other Information: Founded in 1998 and based in Dallas, Texas, Enhabit, Inc. was previously known as Encompass Health Home Health Holdings, Inc. The company focuses on individualized care plans for patients with chronic diseases and conditions, enhancing its value proposition in the healthcare market.
EHAB
Enhabit Inc (EHAB)

When did it IPO

2022

Staff Count

10,800

Country

United States

Sector/Industry

Healthcare/Medical Care Facilities

CEO

Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T.

Market Cap

$383.7M

Enhabit Inc (EHAB) Financial Data

In 2023, EHAB generated $1.05B in revenue, which was a decrease of -2.32% from the previous year. This can be seen as a signal that EHAB's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$1.08B

Revenue From 2021

$1.11B

2.63 %
From Previous Year

Revenue From 2022

$1.07B

-3.21 %
From Previous Year

Revenue From 2023

$1.05B

-2.32 %
From Previous Year
  • Revenue TTM $1.04B
  • Operating Margin TTM 4.3%
  • Gross profit TTM $510.7M
  • Return on assets TTM 1.6%
  • Return on equity TTM -1.0%
  • Profit Margin -0.8%
  • Book Value Per Share 13.49%
  • Market capitalisation $383.7M
  • Revenue for 2021 $1.11B
  • Revenue for 2022 $1.07B
  • Revenue for 2023 $1.05B
  • EPS this year (TTM) $-0.17

Enhabit Inc (EHAB) Latest News

News Image

Thu, 17 Oct 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Enhabit, Inc. (NYSE: EHAB) has been recognized by the Institute for Healthcare Improvement as an Age-Friendly Health Systems Participant, focusing on essential care elements for older patients.

Why It Matters - Enhabit's recognition as an Age-Friendly Health Systems Participant enhances its reputation, potentially attracting more clients and improving financial performance in the growing senior care market.

News Image

Tue, 08 Oct 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Enhabit, Inc. (NYSE: EHAB) will report Q3 results on Nov. 6, 2024, and hold a conference call on Nov. 7 at 10 a.m. EST. Participation details include a toll-free number and conference ID.

Why It Matters - Enhabit's upcoming quarterly results and conference call could influence stock performance and investor sentiment, providing insights into the company's financial health and growth prospects.

News Image

Fri, 04 Oct 2024

Sentiment - NEGATIVE

Source - GuruFocus

Summary - On September 30, 2024, Vanguard Group reduced its holdings in Enhabit Inc (EHAB) by 626,911 shares, bringing its total stake to 2,976,480 shares.

Why It Matters - Vanguard's reduction in Enhabit shares signals potential concerns about the company's outlook, possibly affecting investor confidence and stock performance.

News Image

Fri, 06 Sep 2024

Sentiment - NEUTRAL

Source - PRNewsWire

Summary - S&P Dow Jones Indices will implement changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices on September 23, 2024, ahead of the quarterly rebalance.

Why It Matters - Changes to the S&P indices can impact stock prices and investor sentiment, affecting portfolio allocations and potentially influencing market trends.

News Image

Wed, 21 Aug 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Enhabit, Inc. (NYSE: EHAB) will participate in the Jefferies Healthcare Services Summit on Aug. 28 and the Wells Fargo Healthcare Conference, featuring CEO Barb Jacobsmeyer and CFO Crissy Carlisle.

Why It Matters - Enhabit's participation in notable investor conferences highlights its commitment to transparency and growth, potentially influencing investor confidence and stock performance.

News Image

Mon, 12 Aug 2024

Sentiment - NEUTRAL

Source - Seeking Alpha

Summary - Enhabit, Inc. (NYSE: EHAB) held its Q2 2024 earnings conference call on August 7, 2024, featuring CEO Barb Jacobsmeyer and CFO Crissy Carlisle.

Why It Matters - The earnings call provides insights into Enhabit's financial performance and future outlook, influencing investor sentiment and stock valuation.

...

EHAB Frequently asked questions

The highest forecasted price for EHAB is $11 from Ryan Langston at TD Cowen.

The lowest forecasted price for EHAB is $8 from Joanna Gajuk from B of A Securities

The EHAB analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.